M&A

Sepracor says it's staying put
Fierce Biotech
Sat, 09/5/09 - 12:43 pm
Sepracor
M&A
Biogen Idec offers to buy Facet for $356M
Bizjournals.com
Sat, 09/5/09 - 12:42 pm
Biogen Idec
Facet Biotech
M&A
Abbott: Now That's How to Grow a Company!
Motley Fool
Fri, 09/4/09 - 06:19 am
Abbott Laboratories
Merck
Schering Plough
Visiogen
M&A
Analyst says Savient Pharma could be bought out after meeting with FDA over gout drug
Yahoo/AP
Thu, 09/3/09 - 02:05 pm
Savient
FDA
gout
M&A
Krystexxa
Abbott Labs to acquire Visiogen for $400 million
Marketwatch
Wed, 09/2/09 - 04:44 pm
Abbott Laboratories
Visiogen
vision care
M&A
Pfizer may pay $525 mln for Brazil drugmaker-report
Reuters
Wed, 09/2/09 - 10:03 am
Pfizer
Brazil
Neo Quimica
M&A
Bristol-Myers finishes $2.1B Medarex acquisition
Yahoo/AP
Tue, 09/1/09 - 05:54 pm
M&A
Bristol-Myers Squibb
Medarex
Hisamitsu completes Noven acquisition
Bizjournals.com
Fri, 08/28/09 - 11:20 am
Hisamitsu
Noven
M&A
Bristol-Myers completes initial Medarex offer
Yahoo/AP
Thu, 08/27/09 - 09:34 am
Medarex
Bristol-Myers Squibb
M&A
GSK seems to dismiss HGS rumour
FT.com
Wed, 08/26/09 - 05:44 pm
GSK
Human Genome Sciences
M&A
Human Genome leads biotech stocks north
Marketwatch
Wed, 08/26/09 - 10:23 am
biotech
Human Genome Sciences
GSK
M&A
Glaxo deal talk boosts Human Genome shares
Yahoo/AP
Tue, 08/25/09 - 05:59 pm
GSK
M&A
Human Genome Sciences
The new sweet spot for biotech buyouts: $1B to $2B
Fierce Biotech
Tue, 08/25/09 - 09:24 am
M&A
biotech
What the $3 Billion P&G Deal Says About the Drug Industry
WSJ Online
Tue, 08/25/09 - 08:22 am
Proctor & Gamble
M&A
Warner Chilcott
MediciNova Acquiring Avigen: A Post-Mortem
Seeking Alpha
Tue, 08/25/09 - 08:05 am
MediciNova
Avigen
M&A
Ligand Pharmaceuticals to buy Neurogen for $11 million in stock, rights to future payouts
Yahoo/AP
Tue, 08/25/09 - 07:51 am
Ligand
Neurogen
M&A
Analysis: Warner Chilcott / P&G
FT.com
Mon, 08/24/09 - 08:37 pm
Warner Chilcott
Proctor & Gamble
M&A
Lonza Makes Offer Valuing Patheon at $460 Million
Bloomberg
Fri, 08/21/09 - 10:03 am
Lonza
Patheon
M&A
Does Teva have Shire in its cross-hairs?
Reuters
Fri, 08/21/09 - 09:57 am
Teva Pharmaceuticals
Shire
M&A
generics
MediciNova to acquire Avigen for $1.24 a share
Marketwatch
Fri, 08/21/09 - 07:38 am
MediciNova
Avigen
M&A

Pages